Therapeutic Asset Ratings
12,938 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
FULVESTRANT
Unresectable Solid Tumor
Relay Therapeutics, Inc.
P1
CC
(46)
Gallium-68 Labelled Fap-2286
Fibrotic Liver Disease
Thomas Hope
P1
CC
(46)
Gallium-68 Labelled Fap-2286
Pulmonary Fibrosis
Thomas Hope
P1
CC
(46)
GB491
Non-Small Cell Lung Carcinoma
Genor Biopharma Co., Ltd.
P1
CC
(46)
GLUCOSE, ANHYDROUS
Diabetes Mellitus
Technische Universität Dresden
P1
CC
(46)
hb-2121
Celiac Disease
Nielsen Fernandez-Becker
P1
CC
(46)
Hmbd-002
Non-Small Cell Lung Carcinoma
Hummingbird Bioscience
P1
CC
(46)
Hmpl-760
B-Cell Non-Hodgkin Lymphoma
Hutchmed
P1
CC
(46)
Humulin R
Hyperinsulinemia
Columbia University
P1
CC
(46)
hy-0102
Metastatic Neoplasm
Shanghai HyaMab Biotech Co.,Ltd.
P1
CC
(46)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Malignant Pancreatic Neoplasm
OHSU Knight Cancer Institute
P1
CC
(46)
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER
Hormone Receptor-Positive Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute
P1
CC
(46)
in1011-n17
Osteoarthritis
iN Therapeutics Co., Ltd.
P1
CC
(46)
Inca32459-101
Cancer
Incyte Corporation
P1
CC
(46)
Inno-206
Advanced Solid Tumours
Racura Oncology Ltd
P1
CC
(46)
Inotuzumab Ozogamicin
Adult Acute Lymphoblastic Leukemia
Ruijin Hospital
P1
CC
(46)
Ipilimumab
Breast Adenocarcinoma
National Cancer Institute (NCI)
P1
CC
(46)
Irinotecan
Advanced Solid Tumours
AstraZeneca
P1
CC
(46)
Irinotecan
Juvenile Myelomonocytic Leukemia
Johns Hopkins All Children's Hospital
P1
CC
(46)
Itraconazole
Breast Cancer
Shandong Suncadia Medicine Co., Ltd.
P1
CC
(46)
Itraconazole
Alzheimer Disease
Merck Sharp & Dohme LLC
P1
CC
(46)
Itraconazole
Healthy Volunteer
Sanofi
P1
CC
(46)
Itraconazole
HER2 Mutation
Bayer
P1
CC
(46)
Ivacaftor
Healthy Volunteer
Qanatpharma Canada LTD
P1
CC
(46)
Jnj-64264681
Non-Hodgkin Lymphoma
Janssen Research & Development, LLC
P1
CC
(46)
Showing 651 to 675 of 12,938 assets
Previous
Page 27 of 518
Next
